Panel Discussion: Mobilizing Precision Cancer Care Through the Precision Cancer Consortium to Standardize Testing Pathways & Reduce Access Barriers

9:00 am - Thursday 8th October 2026

  • What is the PCC, our mission, and why is a consortium driving the charge for comprehensive biomarker testing?

Speakers:

Vice President, Scientific Affairs, Global Oncology Diagnostics
AstraZeneca
Global Commercial Strategy, Precision Medicine Lead
Bristol Myers Squibb
Senior Director, Precision Medicine Access
Johnson & Johnson Innovative Medicine